Drug Trial Radar · NCT03137381
Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata
Last checked: Nov 19, 2026Latest source record: Jul 19, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
149
Actual
Start
Aug 9, 2017
Primary completion
Jul 8, 2019
Study completion Jul 8, 2019
Sponsor
- Lead sponsor
- Concert PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- May 2, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the safety and efficacy of CTP-543 on hair loss in adults with chronic, moderate to severe alopecia areata.
Conditions
- Alopecia Areata
Interventions
CTP-543Drug
Administered as tablets.
CTP-543 matching placeboDrug
Administered as tablets.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving at Least a 50% Relative Reduction in Severity of Alopecia Tool (SALT) Score From Baseline at Week 24Time frame: Week 24
- Number of Participants Experiencing at Least One Treatment-Emergent Adverse Event (TEAE)Time frame: From first dose of study drug up to safety follow up at Week 28
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
University of California, Irvine
Irvine, California
Contour Dermatology & Cosmetic Surgery Center
Rancho Mirage, California
Stanford University School of Medicine
Redwood City, California
Kaiser Permanente Northern California
San Francisco, California
Yale School of Medicine
New Haven, Connecticut
Siperstein Dermatology Group
Boynton Beach, Florida
Northwestern University
Chicago, Illinois
Minnesota Clinical Study Center
Fridley, Minnesota
Icahn School of Medicine at Mt. Sinai
New York, New York
Wake Forest University Health Sciences
Winston-Salem, North Carolina
Cleveland Clinic
Cleveland, Ohio
Northwest Dermatology
Portland, Oregon
Suzanne Bruce & Associates, PA
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.